Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer

BACKGROUND: Metformin is the first-line blood sugar control drug for type 2 diabetes, but recent epidemiological studies have shown that it inhibits the growth of a variety of tumours. However, few studies have examined metformin effects on gastric cancer (GC), and the anticancer mechanism has not b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Su, Yue, Chao, Chen, Huanqiu, Chen, Yun, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245468/
https://www.ncbi.nlm.nih.gov/pubmed/32547075
http://dx.doi.org/10.2147/OTT.S242298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245468/
https://www.ncbi.nlm.nih.gov/pubmed/32547075
http://dx.doi.org/10.2147/OTT.S242298

Ejemplares similares